Real life experience on the effect of Belimumab in patients with active systemic lupus.

INTRODUCTION

To evaluate real life experience on the effect of Belimumab in patients with active systemic lupus erythematosus.

CASE PRESENTATION

Twenty patinets with musclesketal symptoms were evaluated, three were discontinued for different resons and seventeen completed eight injections of Belimumab during a six month period. A fatigue score was also evaluated at the same time.

DISCUSSION AND EVALUATION

Marked reduction of disease activity and fatigue score were observed in the patient group.

CONCLUSIONS

Belimumab is a novel form of therapy in patients with active systemic lupus erythematosus to be added in the standard of care particularly in patients with skin and joint symptoms.